Fabrizio Chiti: Aggregation from Every Angle

Credit: © 2007 PAOLO CAPPELLI" /> Credit: © 2007 PAOLO CAPPELLI On weekends, Fabrizio Chiti can be found behind the wheel of his RV, exploring the Italian countryside with his wife and daughter. A decade ago, as an undergraduate at the University of Florence, Chiti never imagined he would be doing science in his home country, let alone in the same department where he became fascinated by proteins. "I was told there were no chances for me," Chiti says. "The opportunities and funding f

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

On weekends, Fabrizio Chiti can be found behind the wheel of his RV, exploring the Italian countryside with his wife and daughter. A decade ago, as an undergraduate at the University of Florence, Chiti never imagined he would be doing science in his home country, let alone in the same department where he became fascinated by proteins. "I was told there were no chances for me," Chiti says. "The opportunities and funding for science were not very good in Florence at that period."

A young Chiti heeded the warning and left for the University of Oxford in 1996 to do his doctoral work with Chris Dobson. Chiti spent three years researching the folding properties of muscle acylphosphatase. Before Chiti's graduation, however, Dobson's interests shifted to protein aggregation, and Chiti was reluctant to follow. "I was deeply involved in protein folding," Chiti says. Dobson wanted his student to explore the possibility ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies